Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. (AVTX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
avtx · stock forecast · 9 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 9 Wall Street analysts in the past 3 months
Buy
9 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$60.00
Consensus
$47.14
+258.2% upside
Low
$34.00
Median: $48 · Last Close: $13.16
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$47.14
258.2% upside
High Target
$60
355.9%
Low Target
$34
158.3%
Current Price
$13.16
as of today
Based on analyst price targets, the AVTX stock price prediction for the next 12 months ranges from $34 to $60. The consensus AVTX price forecast of $47.14 implies 258.2% upside from the current price of $13.16.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $12.50 | ↓ 5.00% |
1-day model range: $12.03–$12.98. Peak: $12.98 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -49.1% |
| 2028 | — | -61.6% |
| 2029 | — | -66.3% |
| 2030 | — | -68.4% |
| 2031 | — | -69.4% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · AVTX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-14 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-14 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-05-14 | Mizuho | Maintains | Outperform→Outperform |
| 2026-05-11 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-05-06 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-06 | BTIG | Maintains | Buy→Buy |
| 2026-05-06 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-04-13 | BTIG | Maintains | Buy→Buy |
| 2026-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Avalo Therapeutics, Inc. (AVTX) stock. Of the recent 23 rating actions, 1 were upgrades and 4 were downgrades. 9 analysts currently cover AVTX.
Analyst Recommendation Trends
AVTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 8 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
↑ 7102.5% YoY
Revenue Next Year
$1M
↑ 0.0% YoY
EPS This Year
$-3.16
EPS Next Year
$-3.15
↓ 0.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast AVTX EPS of $-3.16 for the current fiscal year, based on estimates from 8 analysts. The AVTX revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AVTX stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AVTX price target is $47.14 (+258.2% upside), with an analyst consensus of Buy.
The AVTX short-term stock prediction for tomorrow is $12.50 (-5.00%). The AVTX stock prediction for 2030 projects a range of $3–$5.
Avalo Therapeutics, Inc. trades on NASDAQ under the ticker AVTX. The AVTX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 78% of covering analysts.
Frequently asked questions
AVTX forecast · 8 questionsAccording to 9 Wall Street analysts, the average 12-month AVTX price target is $47.14, with a high forecast of $60.00 and a low of $34.00. The median price target is shown in the chart above when available. This implies +258.2% potential upside from the current price of $13.16.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.